Name: Inoviq (IIQ) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

IIQ

Inoviq

Health Care Equipment & Services

Inoviq is an Australian biotechnology company focused on developing and commercializing innovative cancer diagnostic products. The company's focus is on improving cancer detection and monitoring through its proprietary technologies. Inoviq aims to address unmet needs in cancer diagnostics, offering potential benefits for patients and healthcare providers.

Short position

short percentage0.00%

reported shorts27

shares on issue140.775M

Inoviq (ASX:IIQ) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 27 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.58% in October 2025. IIQ is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads IIQ today

Zanger BreakoutWatchScore 13rank 1580 of 1947
CAN SLIMNot a candidate
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutNot a candidate
Quality compoundersNot a candidate

Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

IIQ fundamentals

In the year to 30 Jun 2026, Inoviq (ASX:IIQ) recorded revenue of A$432.0K and a net loss after tax of A$7.5M. Net margin −1,737.1% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 29 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →